FFA
SMTI icon

Farther Finance Advisors’s Sanara MedTech SMTI Stock Holding History

Farther Finance Advisors’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19K Buy
50
+37
+285% +$765 ﹤0.01% 5325
2026
Q1 		$224 Buy
+13
New +$267 ﹤0.01% 5412

Other funds holding SMTI

SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return
WETS
Wealth Enhancement Trust Services Sioux Falls, South Dakota $900M AUM

Farther Finance Advisors's SMTI Position: Q2 2026 in Review

Farther Finance Advisors increased its Sanara MedTech (SMTI) stake by 285% in Q2 2026, buying an estimated $765 and bringing the position to 50 shares worth $1.19K. The position accounts for ﹤0.01% of the portfolio, ranked #5325.

Farther Finance Advisors first reported a position in SMTI in Q1 2026 and has held it in 2 quarters since. 10 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • Farther Finance Advisors held 50 shares of Sanara MedTech worth $1.19K as of Q2 2026.
  • Farther Finance Advisors bought 37 Sanara MedTech shares in Q2 2026, an estimated $765.
  • Sanara MedTech made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5325 holding.
  • Farther Finance Advisors first reported a position in Sanara MedTech in Q1 2026 and has held it in 2 quarters since.
  • 10 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.